A Study of the Safety and Efficacy of the Combination of Gemcitabine and Docetaxel With MORAb-004 in Metastatic Soft Tissue Sarcoma
Latest Information Update: 22 Aug 2019
At a glance
- Drugs Ontuxizumab (Primary) ; Docetaxel; Gemcitabine
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- Acronyms SOURCE
- Sponsors Morphotek
- 29 Apr 2019 Results (n=209) were published in the Cancer.
- 28 Sep 2016 Status changed from active, no longer recruiting to completed.
- 28 Apr 2016 Planned End Date changed from 1 Apr 2016 to 1 May 2016.